GSTCD-AS1

Across TCGA pan-cancer cohorts, GSTCD-AS1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated GSTCD-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher GSTCD-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GSTCD-AS1 expression acts as an unfavorable survival marker, although some lineages such as LUSC and LUAD show a favorable association.

KIRC, LIHC, and ACC are the cancer types where GSTCD-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.513	0.725	<.001	106	view →
LIHC	DFS	Median	All	0.469	0.609	.001	50	view →
ACC	OS	Median	All	0.432	0.743	.005	42	view →
LUSC	OS	Quartile	II,III,IV	0.805	0.585	.004	41	view →
LUAD	OS	Quartile	III,IV	0.828	0.302	<.001	41	view →
SKCM	OS	Median	IV	0.836	0.293	.001	30	view →
HNSC	DFS	Tertile	All	0.759	0.634	.003	30	view →
KICH	OS	Median	III,IV	0.556	1.000	.010	28	view →
UVM	OS	Tertile	All	0.771	1.000	.008	25	view →
PAAD	DFS	Median	II,III,IV	0.571	0.310	.005	22	view →
UCS	DFS	Median	II,III,IV	0.478	0.249	.028	10	view →
READ	DFS	Tertile	IV	0.179	0.936	.010	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

GSTCD-AS1–KIRC (DFS)

Open the KIRC breakdown →